Weil Advises Montagu Private Equity in its $725 Million Sale of Centor to Gerresheimer AG

Weil is advising Montagu Private Equity LLP (“Montagu”) in its proposed $725 million sale of Centor (formerly known as Rexam Healthcare Prescription Retail) to Gerresheimer AG.

Based in Perrysburg, Ohio, Centor is a manufacturer in the U.S. prescription retail market, providing plastic instruments used by pharmacies in the U.S. to measure the exact count of pills to patients. The company was acquired by Montagu from Rexam PLC in May 2014.

The Weil team advising Montagu is led by Corporate partners Shayla Harlev and David Aknin and includes Tax partners Edouard de Lamy and Mark Schwed; Banking & Finance partner Courtney Marcus; Litigation partner Patrick O’Toole; Technology & IP Transactions partner Jeffrey Osterman; Environmental partner Annemargaret Connolly; Regulatory counsel John O’Loughlin; Employment Litigation counsel Lawrence Baer; Antitrust counsel Vadim Brusser; Real Estate counsel Elliot Ganchrow; Environmental counsel Matthew Morton; Tax counsel Oliver Walker; Executive Compensation & Benefits counsel Jeffrey Lieberman; Corporate associates Mariel Dator, Kelly Wagner, Katherine Meister, James Harvey, Matt Cohn and Ryan Taylor; Tax associates Ryan Roberts, Jonathan Macke and William Dong; Litigation associate Marjan Hajibandeh; Banking & Finance associates Vynessa Nemunaitis and Aaron Turner; Technology & IP Transactions associates Muzaffar Shah and Mary Lentowski; Executive Compensation & Benefits associateJennifer Britz; Employment Litigation associate Thomas McCarthy; and Real Estate associate Mallory Muse.